A CTL assay requiring only 150 μl of mouse blood

This publication has 16 references indexed in Scilit:

• Adoptive-transfer therapy of tumors with the tumor-specific primary cytotoxic T cells induced in vitro with the B7.1-transduced MCA205 cell line
  Cancer Immunology, Immunotherapy, 1999
• Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1
  International Journal of Cancer, 1999
• The shared tumor-specific antigen encoded by mouse geneP1A is a target not only for cytolytic T lymphocytes but also for tumor rejection
  European Journal of Immunology, 1998
• Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
  Nature Medicine, 1998
• Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
  Nature Medicine, 1998
• New treatment options for patients with melanoma: review of melanoma-derived T-cell epitope-based peptide vaccines
  Melanoma Research, 1996
• CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help.
  The Journal of Experimental Medicine, 1993
• Mouse tumor rejection antigens P815A and P815B : Two epitopes carried by a single peptide
  European Journal of Immunology, 1992
• Characterization of two distinct major histocompatibility complex class I Kk-restricted T-cell epitopes within the influenza A/PR/8/34 virus hemagglutinin
  Journal of Virology, 1991
• Clonal analysis of cytolytic T lymphocyte specificity. I. Phenotypically distinct sets of clones as the cellular basis of cross-reactivity to alloantigens.
  The Journal of Experimental Medicine, 1980